In this presentation Jorge Mera, MD, discusses preventing, monitoring, and treating infectious diseases for people with substance use disorders. He discusses a clinical case, the syndemic of HIV, HCV, STIs… […]
Keyword: mat
Evaluation of Infectious Diseases in People with SUD | November 9, 2022
In this presentation Jorge Mera, MD, discusses evaluation of infectious diseases for people with substance use disorders. He discusses a clinical case, the syndemic of HIV, HCV, STIs and SUDs, the… […]
Read More… from Evaluation of Infectious Diseases in People with SUD | November 9, 2022
MAT & Sublocade within the Federal Bureau of Prisons | November 15, 2022
In this presentation, LCDR Samantha Hoke provides a comprehensive review of Medication-Assisted Treatment (MAT), including the use of Sublocade and related FAQs within the Federal Bureau of Prisons (BOP). […]
Read More… from MAT & Sublocade within the Federal Bureau of Prisons | November 15, 2022
Preventing, Monitoring and Treating Infectious Diseases in the MAT Clinic | November 3 2022
In this presentation Whitney Essex, APRN-CNP shares on prevention, monitoring, and treating infectious diseases in the setting of pharmacotherapy for substance use disorders. She discusses infectious diseases associated with substance use… […]
Language of Addiction | October 19, 2022
Dr. Karla Thornton, Professor of Infectious Diseases at the University of New Mexico Health Sciences Center, speaks about the importance of using non-stigmatizing language in substance use and shares the… […]
Starting and Expanding MAT Programs | October 25, 2022
In this discussion, Dr. Ashely Quanbeck, MD, and Dr. Bradley Moran, PharmD, share on their efforts and lessons learned in starting Medications for Opioid Use Disorder Programs (MOUD). Dr. Moran… […]
Read More… from Starting and Expanding MAT Programs | October 25, 2022
Harm Reduction, SSPs, and Me | May 5, 2022
In this presentation, Jessica Rienstra, RN, BSN, discusses the goals of Harm Reduction and how it is used throughout healthcare and in our daily lives. She also discusses the cost… […]
Microdose Buprenorphine Induction | April 7, 2022
In this presentation, Dr. Jonathan Robbins, MD, defines buprenorphine microdosing and several protocols for microinduction. Additionally, case studies from both inpatient and outpatient settings are reviewed as well as guidelines… […]
Read More… from Microdose Buprenorphine Induction | April 7, 2022
MAT and the HCV Provider | March 23, 2022
In this presentation Dr. Jessica Gregg provides an overview of screening, treatment options, and individualized care for patients with substance use disorder and hepatitis C virus. The trifecta of interventions… […]
Sample CPA (BOP)
Sample Collaborative Practice Agreement (CPA) for Pharmacy Delivered Patient Care Services, including Diabetes, Hepatitis C, and Medication-Assisted Treatment within the Federal Bureau of Prisons (BOP) […]











































